We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.14B
AUM Growth
-$67M
Cap. Flow
-$232M
Cap. Flow %
-7.39%
Top 10 Hldgs %
17.34%
Holding
430
New
63
Increased
87
Reduced
126
Closed
57

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$36.9M
2
MCHP icon
Microchip Technology
MCHP
+$29.9M
3
COST icon
Costco
COST
+$24.9M
4
ABMD
Abiomed Inc
ABMD
+$23.6M
5
BIIB icon
Biogen
BIIB
+$17.5M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$33.1M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$27.6M
3
COP icon
ConocoPhillips
COP
+$26.9M
4
DVN icon
Devon Energy
DVN
+$26.3M
5
DIS icon
Walt Disney
DIS
+$25.3M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 15.64%
3 Consumer Discretionary 13.94%
4 Industrials 13.85%
5 Energy 13.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
26
DELISTED
Abiomed Inc
ABMD
$33.2M 1.06%
303,577
+236,920
+355% +$23.6M
MBLY
27
DELISTED
Mobileye N.V.
MBLY
$32.5M 1.04%
704,930
-58,750
-8% -$2.25M
MCHP icon
28
Microchip Technology
MCHP
$39.5B
$31.4M 1%
1,237,280
+1,202,960
+3,505% +$29.9M
PANW icon
29
Palo Alto Networks
PANW
$257B
$30.4M 0.97%
1,489,560
+102,840
+7% +$2.38M
JBHT icon
30
JB Hunt Transport Services
JBHT
$25.6B
$29.4M 0.94%
362,820
-121,780
-25% -$10.1M
CVS icon
31
CVS Health
CVS
$136B
$27.9M 0.89%
291,200
+11,290
+4% +$1.13M
RHT
32
DELISTED
Red Hat Inc
RHT
$27.7M 0.88%
381,820
+52,050
+16% +$3.9M
EFA icon
33
iShares MSCI EAFE ETF
EFA
$76.6B
$27.2M 0.87%
487,500
-480,000
-50% -$27.6M
COST icon
34
Costco
COST
$433B
$26.3M 0.84%
167,180
+164,380
+5,871% +$24.9M
GILD icon
35
Gilead Sciences
GILD
$167B
$26M 0.83%
312,130
-24,780
-7% -$2.2M
FDX icon
36
FedEx
FDX
$73.4B
$22.9M 0.73%
151,180
-123,680
-45% -$20.1M
CBRE icon
37
CBRE Group
CBRE
$43.6B
$22.9M 0.73%
864,090
-72,300
-8% -$2.11M
EPD icon
38
Enterprise Products Partners
EPD
$83.9B
$20.7M 0.66%
708,355
– –
LGND icon
39
Ligand Pharmaceuticals
LGND
$5.8B
$20.6M 0.66%
276,357
-65,965
-19% -$4.9M
DIS icon
40
Walt Disney
DIS
$171B
$18.5M 0.59%
188,880
-253,440
-57% -$25.3M
STE icon
41
Steris
STE
$22.9B
$18.4M 0.59%
267,577
-3,895
-1% -$273K
NKE icon
42
Nike
NKE
$63.6B
$18.1M 0.58%
328,390
-580,290
-64% -$33.1M
SLCA
43
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$18M 0.57%
521,760
-132,165
-20% -$3.66M
CHRW icon
44
C.H. Robinson
CHRW
$19.8B
$17.8M 0.57%
239,610
-20,330
-8% -$1.49M
EEFT icon
45
Euronet Worldwide
EEFT
$3.17B
$16.6M 0.53%
240,448
+100,480
+72% +$7.65M
APC
46
DELISTED
Anadarko Petroleum
APC
$16.4M 0.52%
308,000
+196,000
+175% +$9.93M
WOOF
47
DELISTED
VCA Inc.
WOOF
$16.3M 0.52%
240,730
-4,590
-2% -$291K
BIIB icon
48
Biogen
BIIB
$30.8B
$16.1M 0.51%
+66,490
New +$17.5M
CRTO icon
49
Criteo
CRTO
$1.1B
$16.1M 0.51%
349,675
+8,940
+3% +$385K
POST icon
50
Post Holdings
POST
$4.41B
$15.1M 0.48%
279,245
-68,179
-20% -$3.3M
1
2
3 4 5

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

Castleark Management's Q2 2016 Portfolio in Review

As of Q2 2016, Castleark Management held 430 positions worth $3.14B, down 2.1% from $3.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management withdrew a net $232M in Q2 2016, closing 57 positions and reducing 126 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Biogen worth $16.1M.

  • Castleark Management's largest Q2 2016 buy was Biogen: 66,490 shares worth $16.1M.
  • Castleark Management added most to Medtronic in Q2 2016, an estimated $36.9M increase.
  • Castleark Management's biggest Q2 2016 reduction was Nike, cutting an estimated $33.1M.
  • Castleark Management fully exited Nuance Communications, Inc. in Q2 2016, selling an estimated $16M.
  • Castleark Management's ten largest holdings make up 17% of its $3.14B portfolio in Q2 2016.
  • Castleark Management opened 63 new positions and closed 57 in Q2 2016.
  • Castleark Management's portfolio value fell 2.1% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.